托吡卡胺
臨床資料 | |
---|---|
商品名 | Mydriacyl, others |
AHFS/Drugs.com | Monograph |
核准狀況 | |
懷孕分級 |
|
給藥途徑 | Topical eye drops |
ATC碼 | |
法律規範狀態 | |
法律規範 |
|
藥物動力學數據 | |
血漿蛋白結合率 | 45% |
識別資訊 | |
| |
CAS號 | 1508-75-4 |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.014.673 |
化學資訊 | |
化學式 | C17H20N2O2 |
摩爾質量 | 284.36 g·mol−1 |
3D模型(JSmol) | |
| |
|
托吡卡胺(英語:Tropicamide,商品名:Mydriacyl)是一種含氮有機化合物,化學式C17H20N2O2,是視力測試中促進瞳孔放大的藥物[3]。
參考文獻
- ^ Summary for ARTG Entry: 25356 Mydriacyl tropicamide 0.5% eye drops bottle. Therapeutic Goods Administration. [5 June 2023]. (原始內容存檔於5 June 2023).
- ^ Mydriacyl 1% eye drops, solution - Summary of Product Characteristics (SmPC). Electronic Medicines Compendium. 12 February 2020 [29 July 2020]. (原始內容存檔於27 June 2022).
- ^ World Health Organization. Stuart MC, Kouimtzi M, Hill SR , 編. WHO Model Formulary 2008. World Health Organization. 2009: 314. ISBN 9789241547659. hdl:10665/44053 .
外部連結
- Tropicamide. Drug Information Portal. U.S. National Library of Medicine. [2024-02-12]. (原始內容存檔於2021-04-22).